3E80 image
Entry Detail
PDB ID:
3E80
Title:
Structure of Heparinase II complexed with heparan sulfate degradation disaccharide product
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2008-08-19
Release Date:
2008-12-30
Method Details:
Experimental Method:
Resolution:
2.35 Å
R-Value Free:
0.26
R-Value Work:
0.22
R-Value Observed:
0.23
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Heparinase II protein
Chain IDs:A, B, C
Chain Length:749
Number of Molecules:3
Biological Source:Pedobacter heparinus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
PCA A GLN PYROGLUTAMIC ACID
THR A THR GLYCOSYLATION SITE
Primary Citation
Catalytic mechanism of heparinase II investigated by site-directed mutagenesis and the crystal structure with its substrate.
J.Biol.Chem. 285 20051 20061 (2010)
PMID: 20404324 DOI: 10.1074/jbc.M110.101071

Abstact

Heparinase II (HepII) is an 85-kDa dimeric enzyme that depolymerizes both heparin and heparan sulfate glycosaminoglycans through a beta-elimination mechanism. Recently, we determined the crystal structure of HepII from Pedobacter heparinus (previously known as Flavobacterium heparinum) in complex with a heparin disaccharide product, and identified the location of its active site. Here we present the structure of HepII complexed with a heparan sulfate disaccharide product, proving that the same binding/active site is responsible for the degradation of both uronic acid epimers containing substrates. The key enzymatic step involves removal of a proton from the C5 carbon (a chiral center) of the uronic acid, posing a topological challenge to abstract the proton from either side of the ring in a single active site. We have identified three potential active site residues equidistant from C5 and located on both sides of the uronate product and determined their role in catalysis using a set of defined tetrasaccharide substrates. HepII H202A/Y257A mutant lost activity for both substrates and we determined its crystal structure complexed with a heparan sulfate-derived tetrasaccharide. Based on kinetic characterization of various mutants and the structure of the enzyme-substrate complex we propose residues participating in catalysis and their specific roles.

Legend

Protein

Chemical

Disease

Primary Citation of related structures